While many people will respond to Wegovy and Ozempic for weight loss, up to about 15% of people will not respond to the drugs
[1] Surgical resection is the treatment of choice for symptomatic plexiform neurofibromas, though a new drug, selumetinib was approved in 2020, as a systemic therapeutic for inoperable cases in pediatric patients
That matters, because many GLP-1 benefits appear to fade when treatment stops
Samples were filtered through cell strainer tubes and analysed by a FACS Canto II system equipped with 405-nm, 448-nm and 633-nm laser lines
It removes the dead skin layer which leads to reduction of hyperpigmentation
Please note that berberine is not recommended for long-term use, as it may reduce levels of beneficial gut bacteria